Fortunately, they’re hot on the heels of the mechanisms that allow them to affect brain cells.
Johns Hopkins researchers have discovered a method that allows them to coax stem cells to morph into retinal ganglion cells. This type of nerve cells reside in the retina and transmit visual input from the eyes to the brain. If these cells become damaged or die vision-loss conditions develop, such as glaucoma or multiple sclerosis.
For the first time, scientists have developed a treatment for Multiple Sclerosis (MS) that actually reverses the disability. Dr. Richard K. Burt performed the first hematopoietic stem cell transplant (HSCT) for a multiple sclerosis (MS) patient in the United States at Chicago’s Northwestern Memorial Hospital, and the treatment shows great promise.
In a feat that surprised even the scientists who made the experiment, mice disabled by a condition similar to multiple sclerosis (MS) began to walk and even run again after human stem cells had been transplanted. The findings could potentially offer new means of treating MS, a terribly disease which plagues some 2.3 million people worldwide. Growing stem cells and new legs University
Multiple Sclerosis (MS) is one mean, hard, disease. It’s an autoimmune disease – your body basically fails to identify itself, and starts attacking itself, and treatment is very difficult. In MS, the immune system attacks and destroys myelin, the insulating layer that forms around nerves in the spinal cord, brain and optic nerve. When the insulation is destroyed, electrical signals